We are happy to announce that we have partnered up with XboXLab for the distribution of the VLVbio kits in Sweden, Denmark, Finland and Norway!
The M30® and M65® biomarker assays are widely used in the field of hepatology, mostly within the chronic liver diseases such as Metabolic dysfunction-associated steatohepatitis (MASH). The biomarkers are used for IVD in Europe for the identification and diagnosis of MASH patients, as well as for the follow up of intervention effect. Other than the clinical use, the kits are also used in clinical research, where the biomarkers are included in the reduction of screen failure and as a secondary or exploratory end-point to check for treatment effect of new drugs in MASH clinical trials.
To all our Nordic customers, for more information, please visit XboXLab’s webpage or contact them directly:
Tel: +46 107 888 331